Bionema Logo

Investment case

The biopesticide market is growing at a rate 3.5 times faster than the conventional pesticide market, as the demand for residue-free food increases.

  • Pests and diseases are causing £363 billion in global crop damage each year
  • Currently £65 billion of chemical pesticides are used on an annual basis
  • More toxic chemical pesticides are being banned due to their impact on human health and the environment
  • The time and money it takes to bring new, conventional chemical products to market is increasing to an average of 10-12 years – costing around £300 million
  • The cost of bringing biopesticides to market are significantly lower – at around £25 million in five to six years.

There is a high demand for products that can fill the gap in the market caused by the removal of harmful pesticides  – based on the need for ease of use, efficacy, safety, low cost and reliability.

The global biopesticides market is estimated to be valued at US$4.3 billion in 2020 and is projected to grow at a Compound Annual Growth Rate of 14.7% to reach US$8.5 billion by 2025

Unispore formulation technology has a wider host range and applicability.

  • IP protected technology
  • Provides 20-30% higher efficacy than existing products on the market
  • Technology produces 2.5 x higher production than existing products, reducing costs for end users
  • Non toxic to workers, users and consumers
  • Residue free
  • No insect resistance issue
  • Safer environmental footprint

Product sales continue to increase in the UK and Europe – together with increased expansion into new international markets.

  • Nematrident range is well established within the UK and EU markets
  • UniSpore formulation technology is in the commercial product pipeline
  • Unispore G dossier has been submitted to the CTGB for EU Registration
  • Product applications on key crops are increasing with further approvals and label extensions
  • Confirmed commercial and collaborative relationships with strong industry partners.

Building on a core team of professional experts, armed with significant technical, commercial and business experience

  • Strong Board and management team
  • Team has a unique combination of expertise from the academic, commercial and technical sectors and are committed to delivering the highest standards of service
  • Globally renowned biopesticide industry expert and developer of market-leading pest control solutions
  • Dr Owen Jones – former Global Strategy at Suterra LLC and President of IBMA Global – appointed as Board Advisor

Continuous development of sales territories and distributor relationships.

  • Established sales and market strategy for growth through distribution
  • Significant investment by key partners and grant funding awarding bodies
  • Technology-based business with international licensing potential